2L
NUS icon

25 LLC’s Nu Skin NUS Stock Holding History

25 LLC’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14
Closed -$421 – 375
2023
Q2 		$421 Buy
+14
New +$515 ﹤0.01% 596

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

25 LLC's NUS Position: Q3 2023 in Review

25 LLC sold out of Nu Skin (NUS) in Q3 2023, closing a stake of 14 shares — an estimated $421 sold.

25 LLC first reported a position in NUS in Q2 2023 and held it in 1 quarter. The position peaked at $421 in Q2 2023. 212 funds tracked by Wall St. Rank hold NUS as of Q3 2023.

  • 25 LLC reported no remaining Nu Skin position as of Q3 2023 after selling out during the quarter.
  • 25 LLC sold 14 Nu Skin shares in Q3 2023, an estimated $421.
  • 25 LLC first reported a position in Nu Skin in Q2 2023 and held it in 1 quarter.
  • 25 LLC's Nu Skin position peaked at $421 in Q2 2023.
  • 212 funds tracked by Wall St. Rank held Nu Skin as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.